Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Comparing artificial intelligence and physician performance in predicting IDH mutation status in glioma.

NPJ digital medicine·2026
Same author

Radiomics-based preoperative survival prediction in newly diagnosed glioblastoma: A multicohort study with internal and external validation.

Neuro-oncology advances·2026
Same author

<i>Gliomap-GAN</i>: A conditional generative adversarial network to visualize glioblastoma's cell density from contrast-enhanced magnetic resonance imaging.

Neuro-oncology advances·2026
Same author

Radiomics Analysis of Non-Enhancing Lesions After Bevacizumab Administration in Recurrent Glioblastoma.

Bioengineering (Basel, Switzerland)·2026
Same author

Benchmark Algorithm for Surface Electromyography-Based Periodic Limb Movement Detection.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference·2025
Same author

Gyriform infiltration indicates tumor invasion burden of isocitrate dehydrogenase 1/2-wildtype gliomas.

Brain tumor pathology·2025

相关实验视频

Updated: Jul 15, 2025

A Protocol for Explant Cultures of IDH1-mutant Diffuse Low-grade Gliomas
06:27

A Protocol for Explant Cultures of IDH1-mutant Diffuse Low-grade Gliomas

Published on: May 9, 2025

439

[星细胞瘤,IDH-突变的]

Hideyuki Arita1

  • 1Department of Neurosurgery, Osaka International Cancer Institute.

No shinkei geka. Neurological surgery
|September 24, 2023
PubMed
概括

这项研究回顾了IDH突变性星系细胞瘤的最佳管理,这是一种独特的质瘤类型. 对于这种分子定义的瘤来说,外科切除的范围越来越重要.

科学领域:

  • 神经瘤学神经瘤学
  • 分子病理学分子病理学
  • 临床神经学 临床神经学

背景情况:

  • 根据世卫组织中枢神经系统瘤分类,星细胞瘤,IDH突变是由IDH1/2突变定义的,没有1p/19q代选择.
  • 这种分子定义强调了它的相关性,影响了临床管理策略.
  • 之前的临床研究经常将IDH突变性星系细胞瘤与其他类型的质瘤组合在一起.

研究的目的:

  • 讨论IDH突变天体细胞瘤的最佳管理策略.
  • 分析最近的临床研究,包括针对这种特定瘤类型的分子数据.
  • 强调手术切除范围在管理IDH突变性星系细胞瘤中的重要性增加.

主要方法:

  • 审查最近的临床研究,重点研究IDH突变天体细胞瘤.
  • 分子诊断标准的分析 (IDH突变,1p/19q代选择).
  • 评估与瘤分类相关的手术管理结果.

主要成果:

  • 鉴于IDH突变天体细胞瘤被认为是一个独特的分子和临床实体.
  • 最佳的管理需要考虑分子特征.
  • 手术切除的程度是这种类型质瘤患者的治疗结果的一个关键因素.

更多相关视频

Primary Orthotopic Glioma Xenografts Recapitulate Infiltrative Growth and Isocitrate Dehydrogenase I Mutation
09:43

Primary Orthotopic Glioma Xenografts Recapitulate Infiltrative Growth and Isocitrate Dehydrogenase I Mutation

Published on: January 14, 2014

8.1K
Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures
06:32

Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures

Published on: January 9, 2019

7.9K

相关实验视频

Last Updated: Jul 15, 2025

A Protocol for Explant Cultures of IDH1-mutant Diffuse Low-grade Gliomas
06:27

A Protocol for Explant Cultures of IDH1-mutant Diffuse Low-grade Gliomas

Published on: May 9, 2025

439
Primary Orthotopic Glioma Xenografts Recapitulate Infiltrative Growth and Isocitrate Dehydrogenase I Mutation
09:43

Primary Orthotopic Glioma Xenografts Recapitulate Infiltrative Growth and Isocitrate Dehydrogenase I Mutation

Published on: January 14, 2014

8.1K
Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures
06:32

Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures

Published on: January 9, 2019

7.9K

结论:

  • 应根据其分子形状来定制IDH突变性星系细胞瘤的治疗方法.
  • 最近的分子分析对于完善处理方法至关重要.
  • 对IDH突变天体细胞瘤来说,必须更加重视最大安全的手术切除.